SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-23-000057
Filing Date
2023-07-25
Accepted
2023-07-25 16:04:47
Documents
14
Period of Report
2023-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20230724.htm   iXBRL 8-K 28796
2 EX-3.1 a202307258kex31.htm EX-3.1 107028
6 frtx-20230724_g1.jpg GRAPHIC 29102
  Complete submission text file 0000819050-23-000057.txt   355181

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230724.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230724_lab.xml EX-101.LAB 26157
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230724_pre.xml EX-101.PRE 13587
8 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230724_htm.xml XML 2926
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 231108570
SIC: 2836 Biological Products, (No Diagnostic Substances)